Evidence map›Paper›PMID 35841413›Full record

ArticleWorld journal of urology2022

Analysis of copy number alterations in bladder cancer stem cells revealed a prognostic role of LRP1B.

Donatella Conconi, Andrea Jemma, Martina Giambra, Serena Redaelli, Giorgio Alberto Croci, Leda Dalprà, Marialuisa Lavitrano, Angela Bentivegna

Open access · hybridAbstract read
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer.International journal of molecular sciences · 2023
    Article
  6. Insights into the Peritumoural Brain Zone of Glioblastoma:International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Donatella ConconiSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy. donatella.conconi@unimib.it.ORCID http://orcid.org/0000-0001-5665-9558
Andrea JemmaSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy.
Martina GiambraSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy.ORCID http://orcid.org/0000-0002-4980-8743
Serena RedaelliSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy.ORCID http://orcid.org/0000-0003-0415-4085
Giorgio Alberto CrociPathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, 20122, Italy.ORCID http://orcid.org/0000-0001-5979-7841
Leda DalpràSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy.
Marialuisa LavitranoSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy.ORCID http://orcid.org/0000-0003-4852-1318
Angela BentivegnaSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy. angela.bentivegna@unimib.it.ORCID http://orcid.org/0000-0001-7535-846X
University of Milano-Bicocca · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeBladder cancer is the most common malignancy of the urinary tract and one of the most prevalent cancers worldwide. It represents a spectrum of diseases, from recurrent non-invasive tumors (NMIBCs) managed chronically, to muscle infiltrating and advanced-stage disease (MIBC) that requires multimodal and invasive treatment. Multiple studies have underlined the complexity of bladder tumors genome, highlighting many specific genetic lesions and genome-wide occurrences of copy-number alterations (CNAs). In this study, we analyzed CNAs of selected genes in our cohorts of cancer stem cells (CSCs) and in The Cancer Genome Atlas (TCGA-BLCA) cohort with the aim to correlate their frequency with patients' prognosis.

methodsCNAs have been verified on our array-CGH data previously reported on 19 bladder cancer biopsies (10 NMIBCs and 9 MIBCs) and 16 matched isolated CSC cultures. In addition, CNAs data have been consulted on the TCGA database, to search correlations with patients' follow-up. Finally, mRNA expression levels of LRP1B in TGCA cohort were obtained from The Human Protein Atlas.

resultsWe firstly identified CNAs differentially represented between TGCA data and CSCs derived from NMIBCs and MIBCs, and we correlated the presence of these CNAs with patients' follow-up. LRP1B loss was significantly increased in CSCs and linked to short-term poor prognosis, both at genomic and transcriptomic level, confirming its pivotal role in bladder cancer tumorigenesis.

conclusionOur study allowed us to identify potential "predictive" prognostic CNAs for bladder cancer, implementing knowledge for the ultimate goal of personalized medicine.

Indexed as

DNA Copy Number VariationsUrinary Bladder NeoplasmsHumansNeoplasm Recurrence, LocalNeoplastic Stem CellsPrognosisReceptors, LDLUrinary BladderLRP1B protein, humanReceptors, LDLBladder cancerCancer stem cells (CSCs)Copy-number alterationsLRP1BPredictive CNAsPrognosis

Identifiers

PMID35841413
PMCPMC9287687
OpenAlexW4285587969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.